These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11159777)

  • 21. Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers.
    Goldberg ME; Cantillo J; Gratz I; Deal E; Vekeman D; McDougall R; Afshar M; Zafeiridis A; Larijani G
    Anesth Analg; 1999 Feb; 88(2):437-45. PubMed ID: 9972771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers.
    Eger EI; Gong D; Koblin DD; Bowland T; Ionescu P; Laster MJ; Weiskopf RB
    Anesth Analg; 1997 Nov; 85(5):1154-63. PubMed ID: 9356118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sevoflurane degradation to compound A in anaesthesia breathing systems.
    Cunningham DD; Huang S; Webster J; Mayoral J; Grabenkort RW
    Br J Anaesth; 1996 Oct; 77(4):537-43. PubMed ID: 8942344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sevoflurane degradation by soda lime in a circle breathing system.
    Munday IT; Ward PM; Foden ND; Jones RM; Van Pelt FN; Kenna JG
    Anaesthesia; 1996 Jul; 51(7):622-6. PubMed ID: 8758152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro compound A formation in a computer-controlled closed-circuit anesthetic apparatus. Comparison with a classical valve circuit.
    Versichelen LF; Rolly G; Bouche MP; Van Bocxlaer JF; Struys MM; Van Der Herten C; De Leenheer AP; Mortier EP
    Anesthesiology; 2000 Oct; 93(4):1064-8. PubMed ID: 11020762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity.
    Kharasch ED; Frink EJ; Zager R; Bowdle TA; Artru A; Nogami WM
    Anesthesiology; 1997 Jun; 86(6):1238-53. PubMed ID: 9197292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dehydrofluorinated product of sevoflurane by soda lime reacts with ethanol to produce two products.
    Fujü K; Az-ma T; Yuge O
    Drug Metabol Drug Interact; 1996; 13(2):137-44. PubMed ID: 8905245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baralyme dehydration increases and soda lime dehydration decreases the concentration of compound A resulting from sevoflurane degradation in a standard anesthetic circuit.
    Eger EI; Ionescu P; Laster MJ; Weiskopf RB
    Anesth Analg; 1997 Oct; 85(4):892-8. PubMed ID: 9322476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of compound A under low-flow anesthesia is affected by type of anesthetic machine.
    Yamakage M; Kimura A; Chen X; Tsujiguchi N; Kamada Y; Namiki A
    Can J Anaesth; 2001 May; 48(5):435-8. PubMed ID: 11394509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of sevoflurane degradation products in vapor phase samples.
    Cunningham DD; Webster J; Nelson D; Williamson B
    J Chromatogr B Biomed Appl; 1995 Jun; 668(1):41-52. PubMed ID: 7550980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative differences in the production and toxicity of CF2=BrCl versus CH2F-O-C(=CF2)(CF3) (compound A): the safety of halothane does not indicate the safety of sevoflurane.
    Eger EI; Ionescu P; Laster MJ; Gong D; Weiskopf RB; Kerschmann RL
    Anesth Analg; 1997 Nov; 85(5):1164-70. PubMed ID: 9356119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of prolonged low-flow sevoflurane anesthesia on renal and hepatic function.
    Obata R; Bito H; Ohmura M; Moriwaki G; Ikeuchi Y; Katoh T; Sato S
    Anesth Analg; 2000 Nov; 91(5):1262-8. PubMed ID: 11049919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of lithium hydroxide for carbon dioxide absorption prevents formation of compound A during sevoflurane anesthesia].
    Förster H; Behne M; Warnken UH; Asskali F; Dudziak R
    Anaesthesist; 2000 Feb; 49(2):106-12. PubMed ID: 10756964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compound A and carbon monoxide production from sevoflurane and seven different types of carbon dioxide absorbent in a patient model.
    Keijzer C; Perez RS; de Lange JJ
    Acta Anaesthesiol Scand; 2007 Jan; 51(1):31-7. PubMed ID: 17096668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partly exhausted soda lime or soda lime with water added, inhibits the increase in compound A concentration in the circle system during low-flow sevoflurane anaesthesia.
    Moriwaki G; Bito H; Ikeda K
    Br J Anaesth; 1997 Dec; 79(6):782-6. PubMed ID: 9496213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of degradation of sevoflurane by a new carbon dioxide absorbent in humans.
    Mchaourab A; Arain SR; Ebert TJ
    Anesthesiology; 2001 Jun; 94(6):1007-9. PubMed ID: 11465591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No compound a formation with Superia during minimal-flow sevoflurane anesthesia: a comparison with Sofnolime.
    Bouche MP; Versichelen LF; Struys MM; Van Bocxlaer JF; De Leenheer AP; Mortier EP; Rolly G
    Anesth Analg; 2002 Dec; 95(6):1680-5, table of contents. PubMed ID: 12456439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of renal and hepatic toxicity after four hours of 1.25 minimum alveolar anesthetic concentration sevoflurane anesthesia in volunteers.
    Ebert TJ; Messana LD; Uhrich TD; Staacke TS
    Anesth Analg; 1998 Mar; 86(3):662-7. PubMed ID: 9495434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers.
    Ebert TJ; Frink EJ; Kharasch ED
    Anesthesiology; 1998 Mar; 88(3):601-10. PubMed ID: 9523801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal and hepatic function in surgical patients after low-flow sevoflurane or isoflurane anesthesia.
    Bito H; Ikeda K
    Anesth Analg; 1996 Jan; 82(1):173-6. PubMed ID: 8712397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.